Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy
Decitabine is a pyrimidine analogue of nucleoside cytidine, used for the treatment of myelodysplastic syndromes, chronic myelogenous leukemia, and acute myelogenous leukemia. We present a case of cardiomyopathy associated with decitabine used for secondary acute myelogenous leukemia. The patient pre...
Saved in:
Main Authors: | Pradyumna Agasthi, Hemalatha Narayanasamy, Dan Sorajja, James Slack, Farouk Mookadam |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2018/3953579 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood Cancer and the Heart: Light Chain Cardiomyopathy in Refractory Multiple Myeloma
by: Abdulbaril Olagunju, et al.
Published: (2022-01-01) -
Oncolytic Virotherapy for Hematological Malignancies
by: Swarna Bais, et al.
Published: (2012-01-01) -
Hypoxia impairs decitabine-induced expression of HLA-DR in acute myeloid leukaemia cell lines
by: Sam Humphries, et al.
Published: (2025-01-01) -
Effect of decitabine on PD-L2 methylation in whole blood of iodine-induced autoimmune thyroiditis rats
by: Baiming Jin, et al.
Published: (2025-01-01) -
Prevalence of platinum-induced ototoxicity among patients suffering from hematological malignancies – a systematic review
by: Aleksandra Janowiak-Majeranowska, et al.
Published: (2024-07-01)